Correlation Between Eurobio Scientific and Spineguard

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eurobio Scientific and Spineguard at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurobio Scientific and Spineguard into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurobio Scientific SA and Spineguard, you can compare the effects of market volatilities on Eurobio Scientific and Spineguard and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurobio Scientific with a short position of Spineguard. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurobio Scientific and Spineguard.

Diversification Opportunities for Eurobio Scientific and Spineguard

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eurobio and Spineguard is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Eurobio Scientific SA and Spineguard in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spineguard and Eurobio Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurobio Scientific SA are associated (or correlated) with Spineguard. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spineguard has no effect on the direction of Eurobio Scientific i.e., Eurobio Scientific and Spineguard go up and down completely randomly.

Pair Corralation between Eurobio Scientific and Spineguard

Assuming the 90 days trading horizon Eurobio Scientific SA is expected to generate 0.38 times more return on investment than Spineguard. However, Eurobio Scientific SA is 2.63 times less risky than Spineguard. It trades about 0.06 of its potential returns per unit of risk. Spineguard is currently generating about 0.0 per unit of risk. If you would invest  1,592  in Eurobio Scientific SA on August 27, 2024 and sell it today you would earn a total of  983.00  from holding Eurobio Scientific SA or generate 61.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Eurobio Scientific SA  vs.  Spineguard

 Performance 
       Timeline  
Eurobio Scientific 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Eurobio Scientific SA are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Spineguard 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Spineguard are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Spineguard reported solid returns over the last few months and may actually be approaching a breakup point.

Eurobio Scientific and Spineguard Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eurobio Scientific and Spineguard

The main advantage of trading using opposite Eurobio Scientific and Spineguard positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurobio Scientific position performs unexpectedly, Spineguard can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spineguard will offset losses from the drop in Spineguard's long position.
The idea behind Eurobio Scientific SA and Spineguard pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas